Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines

被引：0
|
作者：
Li, Qian [1 ]
Anver, Miriam R. [2 ]
Butcher, Donna O. [2 ]
Gildersleeve, Jeffrey C. [1 ]
机构：
[1] NCI, Med Chem Lab, Frederick, MD 21702 USA
[2] SAIC Frederick Inc, NCI, Frederick, MD 21702 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 237卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
57-CARB
引用
收藏
页码：701 / 701
页数：1
相关论文
共 50 条
  • [31] Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines
    Bilusic, Marijo
    Gulley, James L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (01) : 109 - 117
  • [32] Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials
    Sun, Zhipeng
    Zhu, Yubing
    Xia, Jufeng
    Sawakami, Tatsuo
    Kokudo, Norihiro
    Zhang, Nengwei
    BIOSCIENCE TRENDS, 2016, 10 (02) : 85 - 91
  • [33] Cancer vaccines: What do we need to measure in clinical trials?
    Kudrin, Alex
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3236 - 3240
  • [34] Expression of the tumor associated carbohydrate antigen Tn and immune effectors in invasive breast cancer
    Verret, Benjamin
    Rossoni, Caroline
    Lebeherec, Doris
    Michiels, Stefan
    Castanon-Alvarez, Eduardo
    Leclerc, Claude
    Delaloge, Suzette
    Artaud, Cecile
    Lacroix-Tikri, Magali
    CANCER RESEARCH, 2018, 78 (04)
  • [35] Sialosyl Tn antigen expression is associated with the prognosis of patients with advanced gastric cancer - Reply
    Yamada, T
    Watanabe, A
    Yamada, Y
    Shino, Y
    Tanase, M
    Yamashita, J
    Miwa, T
    Nakano, H
    CANCER, 1996, 78 (01) : 178 - 178
  • [36] DC-based cancer vaccines: lessons from clinical trials
    Brody, JD
    Engleman, EG
    CYTOTHERAPY, 2004, 6 (02) : 122 - 127
  • [37] Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines
    Raez, LE
    Santos, ES
    Mudad, R
    Podack, ER
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (04) : 635 - 644
  • [38] Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines
    Marijo Bilusic
    James L. Gulley
    Cancer Immunology, Immunotherapy, 2012, 61 : 109 - 117
  • [39] Cancer testis antigen (CTAg) expression in early-stage triple negative (TN) breast cancer
    Chionh, F. J.
    Deb, S.
    Chakrabarti, A.
    Seah, J.
    Cebon, J. S.
    White, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials
    Mittendorf, Elizabeth A.
    Alatrash, Gheath
    Xiao, Haile
    Clifton, G. Travis
    Murray, James L.
    Peoples, George E.
    EXPERT REVIEW OF VACCINES, 2011, 10 (06) : 755 - 774
12345